Related Experiment Videos
Lovastatin-acetaminophen subchronic toxicity in mice
1Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201.
Research Communications in Chemical Pathology and Pharmacology
|September 1, 1990
Summary
This study found that combining lovastatin and acetaminophen in mice caused liver damage. Both drugs together significantly increased liver enzymes and led to liver cell swelling.
Area of Science:
- Toxicology
- Pharmacology
- Hepatology
Background:
- Lovastatin is a cholesterol-lowering drug, and acetaminophen is a common pain reliever.
- Concomitant use of medications can lead to unexpected drug interactions and toxicity.
- Understanding the combined effects of lovastatin and acetaminophen is crucial for patient safety.
Purpose of the Study:
- To investigate the subchronic toxicity of a lovastatin-acetaminophen combination.
- To evaluate the effects of co-administration on liver function and histology in mice.
Main Methods:
- A 13-week oral toxicity study was conducted in s/w mice.
- Lovastatin was administered at 30 mg/kg three times weekly.
- Acetaminophen was administered at 0.75% w/v in drinking water.
Main Results:
- Significant increases in serum glutamate-pyruvate transaminase (SGPT), also known as alanine aminotransferase (ALT), were observed in both male and female mice.
- Histopathological examination of the liver revealed centrilobular hepatocyte swelling.
- These findings indicate liver injury in mice exposed to the drug combination.
Conclusions:
- Concomitant exposure to lovastatin and acetaminophen induces hepatic injury in s/w mice.
- The study highlights the potential hepatotoxic effects of this drug combination.
- Further research may be warranted to elucidate the mechanisms of liver injury and assess risks in humans.